The challenger. Trails the leader on the balanced score. Its widest win over the field is analyst sentiment.
The verdict
NMR leads clearly (57/100 vs AFRM 38) under a balanced style, mostly on total return. But AFRM wins on analyst sentiment, so the comparison turns on what you weight. Switch your goal above and watch the scores move.
THE SCORECARD · FACTOR BY FACTOR · the best value in each row is ticked, and a tie ticks every tied column · weight bar shows how much it counts for your goal
P/E bases differ: trailing for AFRM, fiscal 2026 for NMR.
Growth
Revenue & earnings momentum
1×
✓ —
69
—
54
Profitability & quality
Margins & return on capital
1×
✓ Net 44% · ROIC 2%
TTM through Sep 30, 2026
51
Net 8% · ROIC 6%
fiscal 2026
27
Total return
Share-price change with dividends reinvested
1×
5Y −17%/yr
4
✓ 5Y +21%/yr
89
Risk (calm = better)
Volatility & drawdown
1×
β 2.4 · DD −95%
3
✓ β 1.1 · DD −36%
50
Balance sheet†
Debt vs cash cushion
1×
✓ Net debt/EBITDA 28.2×
TTM through Sep 30, 2026
47
Net debt/EBITDA 3.2×
fiscal 2026
28
Dividend & income
Cash paid to you
1×
—
8
✓ 3.34% yield· D
77
Analyst sentiment
Forward EPS growth (consensus)
1×
✓ Est EPS +45%/yr · 16 analysts
100
Est EPS 0%/yr · 1 analysts
49
† Balance sheet is scored on 5 peer percentiles (current ratio, quick ratio, net debt/EBITDA, interest coverage and debt/equity). The cell shows one of them, so a column can lead on the printed number and still lose the row.
The letter beside the dividend yield is our dividend-safety grade (A+ to F), a read on how likely that dividend is to be cut. It does not grade the yield.
Profitability & qualityCurrently 27/100 (Net 8% · ROIC 6%). Taking it to 100 would lift the balanced score by 9 points, the biggest single move available.
Balance sheetCurrently 28/100 (Net debt/EBITDA 3.2×). Taking it to 100 would lift the balanced score by 9 points, the next biggest.
Scores are Tenet composites, 0–100, reweighted for your selected goal. Seven of the eight factors are sector percentiles; analyst sentiment is an absolute curve on forward EPS growth, capped at 100, so two very high-growth names can share the top score. Moat/durability is not scored (qualitative, not measurable). Comparison is decision-support, not a recommendation · past performance does not predict future returns · Not investment advice · prices are each company's own latest close, the newest here being Nov 13, 2026 · valuation, growth, quality and balance scores from the Nov 13, 2026 scoring run · analyst consensus, return, risk and income scores computed Nov 13, 2026.